Opportunity Information: Apply for PA 13 179
Apply for PA 13 179
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Apr 3, 2013 and posted on Apr 3, 2013.
- Applicants must submit their applications by May 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public housing authorities/Indian housing authorities City or township governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) State governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply unless from an Indian organization collaborating with a PD/PI from a U.S. organization. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) is a National Institutes of Health (NIH) discretionary grant opportunity designed to strengthen and expand vaccine-related scientific collaboration between the United States and India. It sits within a long history of formal bilateral science and technology cooperation, including earlier umbrella arrangements such as the Indo-U.S. Science and Technology Sub Commission, the Gandhi-Reagan Science and Technology Initiative, the U.S.-India Fund, and the broader Science and Technology Cooperation Agreement. Building on that foundation, the VAP itself was established through a Memorandum of Understanding signed on July 9, 1987, specifically to promote joint vaccine research and development efforts between the two countries.
The core purpose of this R03 program is to support smaller, targeted collaborative research projects that can contribute to reducing the burden of infectious diseases that matter to India, the United States, the South Asian region, and global public health more broadly. The program encourages proposals that involve U.S.-India partnerships and that address vaccine-related questions across a range of priority pathogens and syndromes. The targeted disease areas named in the opportunity include dengue, influenza (explicitly including avian influenza strains), malaria, enteric diseases, HIV/AIDS, and tuberculosis. Importantly, the announcement makes clear that it is not limited to a single stage of the research pipeline; applicants may propose basic, translational, clinical, or epidemiological vaccine research, allowing projects that range from early discovery work through studies closer to real-world use and population impact.
From a funding mechanics standpoint, this opportunity uses the NIH R03 mechanism, which is typically intended for small, time-limited projects such as pilot studies, feasibility work, or focused research questions that can generate preliminary data and help position teams for larger future grants. The listed award ceiling for this program is $50,000, and there is no cost-sharing or matching requirement. The funding opportunity number is PA-13-179, and it was posted and created on April 3, 2013. The original closing date and the listed current closing date are both May 7, 2016, with an archive date of June 7, 2016, meaning the announcement is now historical/archived rather than an active open solicitation.
Eligibility is broad and includes many categories of U.S. organizations and government entities, such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), small businesses and other for-profit organizations, and a range of governmental units (state, county, city/township, special district), as well as public housing authorities and independent school districts. The opportunity also explicitly recognizes and includes various mission-driven and minority-serving or community-based institution types, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, Asian American and Native American Pacific Islander-serving institutions (AANAPISIs), tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions.
Because the program is specifically built around Indo-U.S. collaboration, it includes special rules for non-U.S. entities. Non-domestic (non-U.S.) organizations and institutions are generally not eligible to apply on their own, except in the specific case of an Indian organization applying in collaboration with a program director/principal investigator (PD/PI) from a U.S. organization. At the same time, the announcement states that non-domestic components of U.S. organizations are eligible to apply, and that foreign components (as defined in the NIH Grants Policy Statement) are allowed. In practical terms, this structure is intended to ensure that projects are genuinely collaborative and anchored by U.S.-India institutional partnerships while still permitting appropriate work to be conducted in-country where it is scientifically and operationally necessary.
Administratively, the opportunity is associated with NIH funding activity categories in health and maps to CFDA numbers 93.855 (Allergy and Infectious Diseases Research) and 93.856 (Microbiology and Infectious Diseases Research). The full archived announcement was provided through the NIH Grants Guide (PA-13-179). For access or technical issues with the online posting, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) - PA-13-179
What is the Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)?
It is a National Institutes of Health (NIH) discretionary grant opportunity using the R03 mechanism to support small, targeted vaccine-related research projects that strengthen and expand scientific collaboration between the United States and India.
What is the main purpose of this grant program?
The core purpose is to fund focused U.S.-India collaborative projects that contribute to reducing the burden of infectious diseases relevant to India, the United States, the South Asian region, and global public health.
How does this program relate to U.S.-India scientific cooperation?
The opportunity sits within a long history of formal bilateral science and technology cooperation (including earlier umbrella arrangements such as the Indo-U.S. Science and Technology Sub Commission, the Gandhi-Reagan Science and Technology Initiative, the U.S.-India Fund, and the broader Science and Technology Cooperation Agreement). The VAP itself was established through a Memorandum of Understanding signed July 9, 1987 to promote joint vaccine research and development between the two countries.
What funding mechanism does this opportunity use?
It uses the NIH R03 mechanism, which is typically intended for small, time-limited projects such as pilot studies, feasibility studies, or focused research questions that can generate preliminary data and support future, larger grant applications.
What is the maximum award amount for this program?
The listed award ceiling is $50,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
What is the funding opportunity number?
The funding opportunity number is PA-13-179.
When was this funding opportunity posted?
It was posted and created on April 3, 2013.
Is this funding opportunity currently open?
No. The original closing date and the listed current closing date are both May 7, 2016, and the archive date is June 7, 2016. This indicates the announcement is historical/archived rather than an active open solicitation.
What diseases or topic areas are specifically targeted?
The opportunity names priority pathogens and syndromes including dengue, influenza (explicitly including avian influenza strains), malaria, enteric diseases, HIV/AIDS, and tuberculosis.
Is the program limited to a specific stage of vaccine research?
No. The announcement allows proposals across basic, translational, clinical, and epidemiological vaccine research, supporting projects from early discovery through studies closer to real-world use and population impact.
Does the program require a U.S.-India partnership?
The program is designed to promote U.S.-India collaboration and encourages proposals that involve partnerships between the two countries. Special eligibility rules for Indian organizations also reinforce that projects should be structured as genuine collaborations anchored by U.S. and Indian institutions.
Which U.S. organizations are eligible to apply?
Eligibility is broad and includes U.S. public and private institutions of higher education, nonprofits (with and without 501(c)(3) status), small businesses, other for-profit organizations, and many types of governmental units (state, county, city/township, and special districts), as well as public housing authorities and independent school districts.
Are minority-serving and community-based institutions included as eligible applicants?
Yes. The opportunity explicitly includes institution and organization types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, Asian American and Native American Pacific Islander-serving institutions (AANAPISIs), tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions.
Can a non-U.S. organization apply as the primary applicant?
In general, non-domestic (non-U.S.) organizations and institutions are not eligible to apply on their own. The specific exception described is an Indian organization applying in collaboration with a program director/principal investigator (PD/PI) from a U.S. organization.
Are foreign components allowed in projects led by U.S. organizations?
Yes. The announcement states that non-domestic components of U.S. organizations are eligible to apply and that foreign components (as defined in the NIH Grants Policy Statement) are allowed.
What is the intended practical effect of the non-U.S. eligibility rules?
The rules are intended to ensure that projects are truly collaborative and anchored by U.S.-India institutional partnerships, while still allowing appropriate scientific work to be conducted in-country when needed for operational or scientific reasons.
Which NIH funding activity category is associated with this opportunity?
The opportunity is associated with NIH funding activity categories in health.
Which CFDA numbers are linked to this announcement?
The opportunity maps to CFDA 93.855 (Allergy and Infectious Diseases Research) and 93.856 (Microbiology and Infectious Diseases Research).
Where was the full announcement made available?
It was provided through the NIH Grants Guide as PA-13-179 and is described as archived.
Who should be contacted for access or technical issues with the online posting?
The listed contact for access or technical issues is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: New York Conservation Innovation Grants
Previous opportunity: NAWCA Mexican Standard Grants
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 179
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 179) also looked into and applied for these:
| Funding Opportunity |
|---|
| AHRQ Patient Centered Outcomes Research (PCOR) Mentored Research Scientist Development Award (K01) Apply for PA 13 181 Funding Number: PA 13 181 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research (PCOR) Mentored Clinical Investigator Award (K08) Apply for PA 13 180 Funding Number: PA 13 180 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Tyler, Texas Roxbury, Massachusetts and Bristol, Florida Apply for HRSA 13 277 Funding Number: HRSA 13 277 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY13 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Republic of Palau) Apply for PA FPH 13 041 Funding Number: PA FPH 13 041 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $145,000 |
| State Systems Development Initiative Grant Program Apply for HRSA 13 268 Funding Number: HRSA 13 268 Agency: Health Resources and Services Administration Category: Health Funding Amount: $25,000 |
| FaceBase 2 Craniofacial Development and Dysmorphology Dataset, Tool, and Resource Development (U01) Apply for RFA DE 14 004 Funding Number: RFA DE 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FaceBase 2 Craniofacial Development and Dysmorphology Data Management and Integration Hub (U01) Apply for RFA DE 14 005 Funding Number: RFA DE 14 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Occupational Safety and Health Research (R01) Apply for PAR 13 129 Funding Number: PAR 13 129 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Family Health Plus (FH ) Project Apply for RFA 620 13 000002 Funding Number: RFA 620 13 000002 Agency: Nigeria USAID Abuja Category: Health Funding Amount: $9,000,000 |
| Advancing Alcohol Screening and Brief Intervention (aSBI) and CHOICES in American Indian and Alaska Native Populations through Training and Technical Assistance Apply for CDC RFA DD13 1301 Funding Number: CDC RFA DD13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| PPHF 2013 Cooperative Agreement to Support Navigators in Federally facilitated and State Partnership Exchanges Apply for CA NAV 13 001 Funding Number: CA NAV 13 001 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| STRENGTHENING RMNCH THROUGH INDIAN HEALTH PROFESSIONAL ASSOCIATIONS AND SCALING UP UPTAKE OF HEALTH, EDUCATIONAL, SOCIAL PROTECTION AND WELFARE INTERVENTIONS AMONG CHILDREN AFFECTED BY HIV/AIDS Apply for APS 386 13 000004 Funding Number: APS 386 13 000004 Agency: India USAID New Delhi Category: Health Funding Amount: $8,000,000 |
| NINDS Stroke Trials Network National Data Management Center (U01) Apply for RFA NS 13 016 Funding Number: RFA NS 13 016 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| NIDCD Research Career Enhancement Award for Established Investigators (K18) Apply for PAR 13 186 Funding Number: PAR 13 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Viral Hepatitis Networking, Capacity Building and Training Apply for CDC RFA PS13 1313 Funding Number: CDC RFA PS13 1313 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Reducing the Duration of Untreated Psychosis in the United States (R01) Apply for PAR 13 187 Funding Number: PAR 13 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 13 188 Funding Number: PAR 13 188 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Methods Development in Natural Products Chemistry (SBIR)(R43) Apply for RFA AT 14 001 Funding Number: RFA AT 14 001 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Methods Development in Natural Products Chemistry (STTR) (R41) Apply for RFA AT 14 002 Funding Number: RFA AT 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| FY13 Announcement of Anticipated Availability of Funds for the Adoption and Implementation of Health Information Technology in Family Planning Services Grants Region 2 Apply for PA FPH 13 043 Funding Number: PA FPH 13 043 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 179", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.